SHPT Drugs Tied With Better Survival in the HD Population With COVID-19
Paricalcitol and/or calcimimetic use is associated with improved survival in patients with COVID-19 receiving maintenance hemodialysis, a study found.
Hemodialysis
Dialysis Facilities Persevered Through Hurricane Ida
Impaired communications, power outages, and clean water availability caused by Hurricane Ida were among the challenges facing dialysis providers in Louisiana.
Pediatric Dialysis Population With Lupus Nephritis Fares Worse
Among children on dialysis, those with lupus nephritis were more likely to be hospitalized.
Study: Closed-Loop Insulin Therapy Safe, Effective in Diabetes Requiring Dialysis
Compared with standard insulin therapy, closed-loop insulin therapy was associated with less time in hypoglycemia.
Home Hemodialysis Failure Linked With Higher Death Risks
A greater understanding of outcomes after home HD treatment failure may help inform clinical decision making and advanced care planning.
Cinacalcet Does Not Up Risk for Severe Gastrointestinal Bleeding in Hemodialysis
Study is the largest to explore this potential safety issue to date.
Study IDs Possible Relationship Between NGAL and CKD-MBD in Dialysis
Neutrophil gelatinase-associated lipocalin (NGAL) is not only a biomarker of kidney injury but also a bone-derived factor involved in metabolism.
Study: Erythropoietin Not Associated With Increased Stroke Risk in Hemodialysis
The factors that may account for any excess stroke risk among ESA users remain unclear.
FDA Wants Another Study Before Deciding on Tenapanor Approval
Tenapanor inhibits the sodium/hydrogen exchanger 3 to control serum phosphorus in adults with CKD on dialysis.
High Oxalate Ups Cardiovascular Risks in Diabetics on Hemodialysis
The highest vs lowest quartile of serum oxalate levels were significantly associated with 40% and 62% increases risks for serious cardiovascular events and sudden cardiac death, respectively.
- Loading...
Loading...
Next post in Hemodialysis
Loading... 
Loading...